The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

Biotech investors have been buzzing around new areas of drug development this year, such as the red-hot obesity market. But ...

Just 800 of the 13,500 patients eligible to start receiving Wegovy, which can help obese people lose 15% of their body weight ...

She would have periods in time where she’d suddenly wake up in the middle of the day and she couldn’t remember anything from ...

Groundbreaking research presented today at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) ...

The importance of this technique becomes even clearer when considering the larger context. An astonishing 100 million ...

New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...

Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that ...

Viking Therapeutics (NASDAQ: VKTX) and Summit Therapeutics (NASDAQ: SMMT) are both up-and-coming biotechs with no sales ...

For those struggling with obesity and the complex metabolic ... for weight loss has taken this influence to a whole new level ...

When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...